At Pisanchyn Law Firm , our dedicated mass tort attorneys are here to help you navigate the legal process and hold pharmaceutical companies accountable for the harm their products have caused
Biodegradable Ultra-Thin Strut Supraflex Cruz Stent is Noninferior to Xience in TUXEDO-II Study Oct 28, 2025 by Natalie Morrison, CRTonline.org A biodegradablepolymer sirolimuseluting stent (BP-SES) with an ultra-thin strut, known Supraflex Cruz, was noninferior for target lesion failure (TLF) compared to the widely-used permanent everolimus-eluting stent (EES) Xience in diabetic patients with multi-vessel disease (MVD) at 1 year, Indias TUXEDO-2 randomized trial found
In reaction to AD, astrocytes experience a shift in profile, one that is reactive and pro-inflammatory while losing homeostatic roles thus disrupting BBB integrity, ion and neurotransmitter buffering, and energy metabolism (Liddelow et al., 2017
This eye-magination is envisioning alternative situations, by projecting innovative ideas into the future, while testing those together with participating actors, and sending the fruits of this confrontation back into potential futures
Key findings: Pancreatogenic Diabetes Mellitus is characterised by progressive insulin deficiency, impaired glucagon counterregulation, and exocrine pancreatic insufficiency, often accompanied by malnutrition and glycaemic instability
Another hormone called the follicle-stimulating hormone (FSH) stimulates the growth of follicles in the ovaries
